Enteropathy-associated T-cell lymphoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{AS}}
==Overview==
==Overview==
Common complications of enteropathy-associated T-cell lymphoma include ulcer, obstruction, and perforation of small intestine.<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>
Common complications of enteropathy-associated T-cell lymphoma include [[ulcer]], [[obstruction]], and [[perforation]] of small intestine.<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>
==Natural History<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>==
==Natural History<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>==
* Enteropathy-associated T-cell lymphoma is associated with celiac disease (sprue)  
* Enteropathy-associated T-cell lymphoma is associated with celiac disease (sprue).
* People with celiac disease cannot tolerate gluten, a protein found in many grains, such as wheat, rye and barley (gluten sensitivity)
* People with celiac disease cannot tolerate gluten, a protein found in many grains, such as wheat, rye and barley (gluten sensitivity).
* A gluten-free diet helps prevent enteropathy-associated T-cell lymphoma from developing, so this type of lymphoma does not commonly occur in people diagnosed with celiac disease at a young age  
* A gluten-free diet helps prevent enteropathy-associated T-cell lymphoma from developing, so this type of lymphoma does not commonly occur in people diagnosed with celiac disease at a young age.
* Most adults are diagnosed with celiac disease at the same time as their lymphoma or shortly before their lymphoma is diagnosed
* Most adults are diagnosed with [[celiac disease]] at the same time as their lymphoma or shortly before their lymphoma is diagnosed.
* Enteropathy-associated T-cell lymphoma may spread to the liver, spleen, lymph nodes, gallbladder, stomach, colon or skin
* Enteropathy-associated T-cell lymphoma may spread to the liver, spleen, lymph nodes, gallbladder, stomach, colon or skin.
==Complications==
==Complications==
* Common complications of enteropathy-associated T-cell lymphoma include:<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>
* Common complications of enteropathy-associated T-cell lymphoma include:<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>
:* Ulcer in small intestine  
:* [[Ulcer]] in small intestine  
:* Obstruction of small intestine
:* [[Obstruction]] of small intestine
:* Perforation of small intestine  
:* [[Perforation]] of small intestine  
==Prognosis==
==Prognosis==
* EATL is usually a fast-growing (aggressive) lymphoma. The prognosis for people with EATL is often not very good.<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>
* EATL is usually a fast-growing (aggressive) lymphoma. The prognosis for people with EATL is often not very good.<ref name= canadiancancer>Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016 </ref>

Revision as of 16:01, 1 February 2016

Enteropathy-associated T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Enteropathy-associated T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Enteropathy-associated T-cell lymphoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis

CDC on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis

Enteropathy-associated T-cell lymphoma natural history, complications and prognosis in the news

Blogs on Enteropathy-associated T-cell lymphoma natural history, complications and prognosis

Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Common complications of enteropathy-associated T-cell lymphoma include ulcer, obstruction, and perforation of small intestine.[1]

Natural History[1]

  • Enteropathy-associated T-cell lymphoma is associated with celiac disease (sprue).
  • People with celiac disease cannot tolerate gluten, a protein found in many grains, such as wheat, rye and barley (gluten sensitivity).
  • A gluten-free diet helps prevent enteropathy-associated T-cell lymphoma from developing, so this type of lymphoma does not commonly occur in people diagnosed with celiac disease at a young age.
  • Most adults are diagnosed with celiac disease at the same time as their lymphoma or shortly before their lymphoma is diagnosed.
  • Enteropathy-associated T-cell lymphoma may spread to the liver, spleen, lymph nodes, gallbladder, stomach, colon or skin.

Complications

  • Common complications of enteropathy-associated T-cell lymphoma include:[1]

Prognosis

  • EATL is usually a fast-growing (aggressive) lymphoma. The prognosis for people with EATL is often not very good.[1]
  • Recurrences most frequent in the small intestine[2]
  • According to the Peripheral T-Cell Lymphoma Project, median overall survival is ten months, while median failure-free survival is only six months
  • The peripheral index for T-cell lymphoma is useful in defining prognosis for enteropathy-associated T-cell lymphoma
  • Among the most influential prognostic factors is bulky disease, defined by a tumor mass greater than 5 cm[3]
  • Autologous stem cell transplantation is feasible for selected patients with enteropathy-associated T-cell lymphoma and can yield durable disease control in a significant proportion of these patients
  • One study found a trend for better survival in patients transplanted in first complete or partial remission at four years (66% vs. 36%; P = .062)[4]

References

  1. 1.0 1.1 1.2 1.3 Enteropathy-associated T-cell lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/enteropathy-associated-t-cell-lymphoma/?region=on Accessed on January 27, 2016
  2. Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 27, 2016
  3. Delabie J, et al. (July 2011). "Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project". Blood. 118 (148): 148. doi:10.1182/blood-2011-02-335216.
  4. Jantunen, E; Boumendil, A; Finel, H; Luan, J. J.; Johnson, P; Rambaldi, A; Haynes, A; Duchosal, M. A.; Bethge, W; Biron, P; Carlson, K; Craddock, C; Rudin, C; Finke, J; Salles, G; Kroschinsky, F; Sureda, A; Dreger, P; Lymphoma Working Party of the EBMT (2013). "Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: A retrospective study by the EBMT". Blood. 121 (13): 2529–32. doi:10.1182/blood-2012-11-466839. PMID 23361910.


Template:WikiDoc Sources